Topol and Teirstein: The Click and Rub Show

View all posts »

Episode #1: Revascularization trials: Bypass vs PCI

May 4, 2009 10:40 EDT


In this inaugural episode, Drs Topol and Teirstein focus on SYNTAX. From the basic questions--Does the trial have value? Has it affected clinical practice?--to the problematic issue of randomizing patients to a 20-minute intervention or a weeklong hospitalization, they also ponder what they have learned from revascularization trials and paper cuts as well as the whimsical image of performing PCI on CV surgeons.








Your comments
Episode #1: Revascularization trials: Bypass vs PCI
# 1 of 3
June 21, 2009 11:12 (EDT)
Emilia Arden, D.O. FACC

This is a great, honest and finaly fare conversation.

Would like to hear other topics.

# 2 of 3
June 22, 2009 10:28 (EDT)
Deepak Natarajan

 

It is important to remember that a topic such as left main PCi vs CABG or for that matter 3 vessel disease PCI vs CABG needs to be discussed in a more detailed fashion than has been done in this first conversation. The interaction holds one’s interest but is too much on the surface.

There are after all other data ( Korean, French and German) already published on left main stenting  in the recent past that merited mention to add more substance.

# 3 of 3
June 25, 2009 10:03 (EDT)
madhup Joshi, MD

great idea for a medical 'radio show'!

It was difficult to ascertain if any definitive conclusions could be reached on the SYNTAX & FREEDOM TRIAL and CABG

And  if these trial are 'underpowered' what would make these trials more balanced so that more conclusive conclusions could be concluded?

 


You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

About the Click and Rub Show
theheart.org brings you a freewheeling and unconventional exchange on the latest cardiology news and events through the eyes of thought leaders Drs Eric Topol and Paul Teirstein from Scripps Translational Research Institute.

We value the diverse opinions of our readership (that includes you!) -- share your thoughts by writing them in the comments box at left and stay tuned for new shows, posted on a monthly basis.